Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, SE-17176 Stockholm, Sweden
AstraZeneca, R and D, Wilmington, DE, United States
Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan
References: Aznavour, N., Rbah, L., Riad, M., Reilhac, A., Costes, N., Descarries, L., Zimmer, L., A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment (2006) Neuroimage, 33, pp. 834-84
Derry, C., Benjamin, C., Bladin, P., Le Bars, D., Tochon-Danguy, H., Berkovic, S.F., Zimmer, L., Reutens, D., Increased serotonin receptor availability in human sleep: Evidence from an [18F]MPPF PET study in narcolepsy (2006) Neuroimage, 30, pp. 341-348
Engel, G., Gothert, M., Hoyer, D., Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT(1B) binding sites (1986) Naunyn-Schmiedeberg's Archives of Pharmacology, 332 (1), pp. 1-7
Gothert, M., Schlicker, E., Fink, K., Classen, K., Effects of RU 24969 on serotonin release in rat brain cortex: Further support for the identity of serotonin autoreceptors with 5-HT(1B) sites (1987) Archives Internationales de Pharmacodynamie et de Therapie, 288 (1), pp. 31-42
Hume, S., Hirani, E., Opacka-Juffry, J., Myers, R., Townsend, C., Pike, V., Grasby, P., Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine (2001) Synapse, 41, pp. 150-159
Janoshazi, A., Deraet, M., Callebert, J., Setola, V., Guenther, S., Saubamea, B., Manivet, P., Maroteaux, L., Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors (2007) Mol Pharmacol, 71, pp. 1463-1474
Koepp, M.J., Gunn, R.N., Lawrence, A.D., Cunningham, V.J., Dagher, A., Jones, T., Brooks, D.J., Grasby, P.M., Evidence for striatal dopamine release during a video game (1998) Nature, 393, pp. 266-268
Laruelle, M., Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review (2000) Journal of Cerebral Blood Flow and Metabolism, 20 (3), pp. 423-451
Maeda, J., Suhara, T., Ogawa, M., Okauchi, T., Kawabe, K., Zhang, M.R., Semba, J., Suzuki, K., In vivo binding properties of [carbonyl-11C]WAY-100635: Effect of endogenous serotonin (2001) Synapse, 40, pp. 122-129
Maura, G., Roccatagliata, E., Raiteri, M., Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor (1986) Naunyn Schmiedebergs Arch Pharmacol, 334, pp. 323-326
Mennini, T., Bizzi, A., Caccia, S., Codegoni, A., Fracasso, C., Frittoli, E., Guiso, G., Garattini, S., Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs (1991) Naunyn Schmiedebergs Arch Pharmacol, 343, pp. 483-490
Mukaida, K., Shichino, T., Koyanagi, S., Himukashi, S., Fukuda, K., Activity of the serotonergic system during isoflurane anesthesia (2007) Anesth Analg, 104, pp. 836-839
Pierson, M.E., Andersson, J., Nyberg, S., McCarthy, D.J., Finnema, S.J., Varnas, K., Takano, A., Halldin, C., [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET) Characterization in the primate brain (2008) Neuroimage, 41, pp. 1075-1085
Praschak-Rieder, N., Hussey, D., Wilson, A.A., Carella, A., Lee, M., Dunn, E., Willeit, M., Meyer, J.H., Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: An [(18)F] MPPF positron emission tomography study (2004) Biol Psychiatry, 56, pp. 587-591
Sayer, T.J., Hannon, S.D., Redfern, P.H., Martin, K.F., Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo Effect of chronic antidepressant drug treatment (1999) Br J Pharmacol, 126, pp. 1777-1784
Sibon, I., Benkelfat, C., Gravel, P., Aznavour, N., Costes, N., Mzengeza, S., Booij, L., Descarries, L., Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: A positron-emission tomography study in healthy volunteers (2008) Biol Psychiatry, 63, pp. 1135-1140
Tomasi, G., Nabulsi, N., Weinzimmer, D., Sandiego, C., Gallezot, J.D., Wang, E., McLean, S., Carson, R.E., In vivo Scatchard analysis of bolus/infusion 5-HT1B studies with [11C]P943: Comparison between SRTM and equilibrium methods (2008) NeuroImage, 41, pp. T16
De Udo Haes, J.I., Bosker, F.J., Van Waarde, A., Pruim, J., Willemsen, A.T., Vaalburg, W., Den Boer, J.A., 5-HT(1A) receptor imaging in the human brain: Effect of tryptophan depletion and infusion on [(18)F]MPPF binding (2002) Synapse, 46, pp. 108-115
Varnäs, K., Hall, H., Bonaventure, P., Sedvall, G., Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [H]GR 125743 (2001) Brain Res, 915, pp. 47-57
Varrone, A., Sjoholm, N., Eriksson, L., Gulyas, B., Halldin, C., Farde, L., Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT (2009) Eur J Nucl Med Mol Imaging, 36, pp. 1639-1650
Volkow, N.D., Wang, G.-J., Fowler, J.S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Wolf, A.P., Imaging endogenous dopamine competition with [11C]raclopride in the human brain (1994) Synapse, 16 (4), pp. 255-262
Zimmer, L., Mauger, G., Le Bars, D., Bonmarchand, G., Luxen, A., Pujol, J.F., Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus Kinetic beta measurements combined with microdialysis (2002) J Neurochem, 80, pp. 278-286
Zimmer, L., Rbah, L., Giacomelli, F., Le Bars, D., Renaud, B., A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus (2003) Journal of Nuclear Medicine, 44 (9), pp. 1495-1501
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Grasby, P. M., Evidence for striatal dopamine release during a video game (1998) Nature, 393, pp. 266-268
Pierson, M. E., Andersson, J., Nyberg, S., McCarthy, D. J., Finnema, S. J., Varnas, K., Takano, A., Halldin, C., [11C] AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET) Characterization in the primate brain (2008) Neuroimage, 41, pp. 1075-1085
Sayer, T. J., Hannon, S. D., Redfern, P. H., Martin, K. F., Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo Effect of chronic antidepressant drug treatment (1999) Br J Pharmacol, 126, pp. 1777-1784
De Udo Haes, J. I., Bosker, F. J., Van Waarde, A., Pruim, J., Willemsen, A. T., Vaalburg, W., Den Boer, J. A., 5-HT (1A) receptor imaging in the human brain: Effect of tryptophan depletion and infusion on [(18) F] MPPF binding (2002) Synapse, 46, pp. 108-115
Varn s, K., Hall, H., Bonaventure, P., Sedvall, G., Autoradiographic mapping of 5-HT (1B) and 5-HT (1D) receptors in the post mortem human brain using [H] GR 125743 (2001) Brain Res, 915, pp. 47-57
Volkow, N. D., Wang, G. -J., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Wolf, A. P., Imaging endogenous dopamine competition with [11C] raclopride in the human brain (1994) Synapse, 16 (4), pp. 255-262
Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain